A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedema
- 31 August 2004
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 51 (2) , 120-123
- https://doi.org/10.1016/j.jaad.2004.03.023
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Diffuse cutaneous mucinosesDermatologic Clinics, 2002
- Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedemaJournal of the American Academy of Dermatology, 2001
- Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg)Journal of the American Academy of Dermatology, 2000
- Scleromyxedema: Treatment with interferon alfaJournal of the American Academy of Dermatology, 1999
- Fatal scleromyxedema: Report of a case and review of the literatureJournal of the American Academy of Dermatology, 1998
- Extracorporeal photochemotherapy: A potentially useful treatment for scleromyxedemaJournal of the American Academy of Dermatology, 1991
- ScleromyxedemaInternational Journal of Dermatology, 1989
- Scleromyxoedema—successful treatment with plasma exchange and immunosuppressionBritish Journal of Dermatology, 1987
- Melphalan Therapy in the Treatment of ScleromyxedemaArchives of Dermatology, 1980
- Über eine eigenartige, der Sklerodermie nahestehende AffektionArchives of Dermatological Research, 1908